Hello and Welcome to Patientsville.com, Your Source for all FENOFIBRATE information. We are dedicated to provide You with FENOFIBRATE safety information. Learn about FENOFIBRATE serious adverse events reported to Food and Drug Administration (FDA).
Medications A-Z: A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
FENOFIBRATE Safety Reports
Total FENOFIBRATE reports: 96.FENOFIBRATE FDA safety alerts: No.
Reported deaths: 4 Reported hospitalizations: 36.
Take FENOFIBRATE Side Effects Survey or Share Your FENOFIBRATE Story. Read More Here.
Showing 1-75 of 96 Next >
Consumer or non-health professional from UNITED STATES reported FENOFIBRATE problem on July 18, 2006. Female patient, 57 years of age, was diagnosed with mixed hyperlipidaemia and was treated with FENOFIBRATE. After drug was administered, patient experienced the following problems/side effects: dilatation ventricular, fungal rash, myocardial ischaemia, polyarthritis, pulmonary oedema, synovitis. FENOFIBRATE dosage: unknown. During the same period patient was treated with LEVOTHYROXINE, NICOTINE, ACETAMINOPHEN W, ACETAMINOPHEN W, AMITRIPTYLINE HYDROCHLORIDE, CHLORPROMAZINE HYDROCHLORIDE. Patient recovered.FENOFIBRATE problem was reported by a Consumer or non-health professional from UNITED STATES on July 18, 2006. Female patient, 74 years of age, was diagnosed with mixed hyperlipidaemia and was treated with FENOFIBRATE. After drug was administered, patient experienced the following problems/side effects: blood pressure increased, cholangitis acute, cholelithiasis, gastric ulcer, hypokalaemia. FENOFIBRATE dosage: unknown. During the same period patient was treated with EZETIMIBE, DOXAZOSIN MESYLATE, FUROSEMIDE, GLIPIZIDE, METFORMIN, METOPROLOL. Patient was hospitalized. Patient recovered.
Health Professional from FRANCE reported FENOFIBRATE problem on Feb 03, 2006. Female patient, 74 years of age, was treated with FENOFIBRATE. After drug was administered, patient experienced the following problems/side effects: antineutrophil cytoplasmic antibody positive, leukopenia, myelodysplastic syndrome. FENOFIBRATE dosage: unknown. During the same period patient was treated with OMEPRAZOLE, CLOMIPRAMINE HYDROCHLORIDE, ALEPSAL, ESBERIVENTE, ASPIRIN, MACROGOL, FERROUS SULPHATE, OXYBUTYNIN. Patient was hospitalized. Patient recovered.
FENOFIBRATE problem was reported by a Consumer or non-health professional from FRANCE on Nov 27, 2006. Female patient, 79 years of age, was diagnosed with hypercholesterolaemia, hypertension and was treated with FENOFIBRATE. After drug was administered, patient experienced the following problems/side effects: lupoid hepatic cirrhosis. FENOFIBRATE dosage: unknown. During the same period patient was treated with DIURETICS. Patient was hospitalized. Patient recovered.
Consumer or non-health professional from UNITED STATES reported FENOFIBRATE problem on Oct 19, 2006. Female patient, 49 years of age, weighting 170.0 lb, was diagnosed with hypercholesterolaemia and was treated with FENOFIBRATE. After drug was administered, patient experienced the following problems/side effects: angina pectoris, dizziness, paraesthesia, presyncope. FENOFIBRATE dosage: 160 MG QD, PO. During the same period patient was treated with ZANTAC, DIOVAN HCT, NULEV, CENTRUM OTC VITAMIN, FIBERCON OTC SUPPLEMENT. Patient was hospitalized. Patient recovered.
FENOFIBRATE problem was reported by a Health Professional from GERMANY on June 29, 2007. Male patient, 55 years of age, was diagnosed with hyperlipidaemia and was treated with FENOFIBRATE. After drug was administered, patient experienced the following problems/side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood alkaline phosphatase increased, blood lactate dehydrogenase increased, gamma-glutamyltransferase increased, hepatic function abnormal, malaise. FENOFIBRATE dosage: unknown. During the same period patient was treated with CANDESARTAN CILEXETIL, PRAVASTATIN, AMLODIPINE BESYLATE, BEZAFIBRATE. Patient recovered.
Health Professional from GERMANY reported FENOFIBRATE problem on July 16, 2007. Male patient, 51 years of age, was diagnosed with hypertriglyceridaemia and was treated with FENOFIBRATE. After drug was administered, patient experienced the following problems/side effects: renal impairment. FENOFIBRATE dosage: unknown. During the same period patient was treated with THIAMAZOLE, LEVOTHYROXINE, SULPIRIDE, FLUVOXAMINE MALEATE, ALPRAZOLAM. Patient recovered.
FENOFIBRATE problem was reported by a Physician from GERMANY on July 19, 2007. Female patient, 78 years of age, was treated with FENOFIBRATE. After drug was administered, patient experienced the following problems/side effects: bone marrow failure. FENOFIBRATE dosage: unknown. During the same period patient was treated with OMEPRAZOLE, FRUMIL, DIGOXIN, LEVOTHYROXINE, WARFARIN, TEMAZEPAM. Patient was hospitalized. Patient recovered.
Health Professional from GERMANY reported FENOFIBRATE problem on Aug 03, 2007. Male patient, 53 years of age, was diagnosed with hyperlipidaemia and was treated with FENOFIBRATE. After drug was administered, patient experienced the following problems/side effects: blood creatine phosphokinase increased, facial spasm, malaise, musculoskeletal chest pain, musculoskeletal pain, neck pain. FENOFIBRATE dosage: unknown. During the same period patient was treated with ZOLPIDEM TARTRATE, LORATADINE, MECOBALAMIN. Patient recovered.
FENOFIBRATE problem was reported by a Health Professional from GERMANY on Aug 10, 2007. Male patient, 51 years of age, was diagnosed with hypertriglyceridaemia and was treated with FENOFIBRATE. After drug was administered, patient experienced the following problems/side effects: renal function test abnormal. FENOFIBRATE dosage: unknown. During the same period patient was treated with THIAMAZOLE, LEVOTHYROXINE, SULPIRIDE, FLUVOXAMINE MALEATE, ALPRAZOLAM. Patient recovered.
Health Professional from GERMANY reported FENOFIBRATE problem on Aug 14, 2007. Male patient, 68 years of age, was diagnosed with hyperlipidaemia and was treated with FENOFIBRATE. After drug was administered, patient experienced the following problems/side effects: jaundice. FENOFIBRATE dosage: unknown. During the same period patient was treated with AMLODIPINE BESYLATE. Patient was hospitalized. Patient recovered.
FENOFIBRATE problem was reported by a Consumer or non-health professional from AUSTRALIA on Aug 09, 2007. Female patient, 65 years of age, was diagnosed with dyslipidaemia, atrial fibrillation, mitral valve repair and was treated with FENOFIBRATE. After drug was administered, patient experienced the following problems/side effects: atrial fibrillation, cardiac disorder, coagulopathy, gastrointestinal haemorrhage, haemarthrosis, international normalised ratio increased, normochromic normocytic anaemia. FENOFIBRATE dosage: unknown. During the same period patient was treated with WARFARIN. Patient was hospitalized. Patient recovered.
Consumer or non-health professional from UNITED STATES reported FENOFIBRATE problem on Aug 30, 2007. Male patient, weighting 360.0 lb, was diagnosed with blood cholesterol increased and was treated with FENOFIBRATE. After drug was administered, patient experienced the following problems/side effects: muscle spasms, muscular weakness, pain. FENOFIBRATE dosage: unknown. During the same period patient was treated with ROSUVASTATIN. Patient recovered.
FENOFIBRATE problem was reported by a Health Professional from GERMANY on Sept 01, 2007. Female patient, 76 years of age, was diagnosed with hyperlipidaemia and was treated with FENOFIBRATE. After drug was administered, patient experienced the following problems/side effects: jaundice. FENOFIBRATE dosage: unknown. During the same period patient was treated with NILVADIPINE, ASPIRIN. Patient was hospitalized. Patient recovered.
Physician from UNITED STATES reported FENOFIBRATE problem on Aug 22, 2007. Male patient, 42 years of age, was diagnosed with blood triglycerides increased and was treated with FENOFIBRATE. After drug was administered, patient experienced the following problems/side effects: complex partial seizures. FENOFIBRATE dosage: 130 MG, QD, ORAL. Patient was hospitalized. Patient recovered.
FENOFIBRATE problem was reported by a Health Professional from UNITED STATES on Aug 23, 2007. Male patient, 85 years of age, weighting 142.0 lb, was treated with FENOFIBRATE. After drug was administered, patient experienced the following problems/side effects: international normalised ratio increased, ocular hyperaemia. FENOFIBRATE dosage: unknown. During the same period patient was treated with COUMADIN, CORDARONE, DIGOXIN, ACCUPRIL, SIMVASTATIN, IRON, INSULIN, ICAPS. Patient recovered.
Consumer or non-health professional from UNITED STATES reported FENOFIBRATE problem on Aug 30, 2007. Female patient, 67 years of age, was treated with FENOFIBRATE. After drug was administered, patient experienced the following problems/side effects: blood creatine phosphokinase increased, blood pressure abnormal, cardiac aneurysm, cardiac disorder, chest pain, ejection fraction decreased, musculoskeletal pain, myoglobin urine present, pain in extremity. FENOFIBRATE dosage: 160 MG QD, PO. During the same period patient was treated with ROSUVASTATIN, HYDROCHLOROTHIAZIDE, OXAPROZIN. Patient was hospitalized. Patient recovered.
FENOFIBRATE problem was reported by a Health Professional from GERMANY on Sept 07, 2007. Male patient, 94 years of age, was diagnosed with hyperlipidaemia and was treated with FENOFIBRATE. After drug was administered, patient experienced the following problems/side effects: blister, erythema. FENOFIBRATE dosage: unknown. During the same period patient was treated with ENALAPRIL MALEATE. Patient recovered.
Pharmacist from GERMANY reported FENOFIBRATE problem on Sept 14, 2007. Female patient, 88 years of age, was diagnosed with diverticulitis and was treated with FENOFIBRATE. After drug was administered, patient experienced the following problems/side effects: agranulocytosis, sepsis. FENOFIBRATE dosage: unknown. During the same period patient was treated with AUGMENTIN, FRUMIL, DIGOXIN, LEVOTHYROXINE, PAROXETINE, TEMAZEPAM. Patient recovered.
FENOFIBRATE problem was reported by a Pharmacist from UNITED STATES on Sept 24, 2007. Male patient, 40 years of age, weighting 198.0 lb, was diagnosed with hyperlipidaemia and was treated with FENOFIBRATE. After drug was administered, patient experienced the following problems/side effects: neutropenia. FENOFIBRATE dosage: 160 MG DAILY PO. Patient recovered.
Health Professional from UNITED KINGDOM reported FENOFIBRATE problem on Sept 11, 2007. Female patient, 88 years of age, was diagnosed with diverticulitis, infection and was treated with FENOFIBRATE. After drug was administered, patient experienced the following problems/side effects: agranulocytosis, sepsis. FENOFIBRATE dosage: 267 MG, ORAL. During the same period patient was treated with AUGMENTIN, DIGOXIN, LEVOTHYROXINE, METRONIDAZOLE, PAROXETINE, TEMAZEPAM. Patient recovered.
Showing 1-75 of 96 Next >